Skip to main content
TipRanks
Go Ultimate75% OFF

Christopher Lowe Insider Profile

4 Followers

Christopher Lowe, Director at Vincerx Pharma Inc, holds 40.00K shares in Vincerx Pharma Inc (Ticker: VINC), holds 265.00K shares in IRulya Therapeutics (Ticker: IRLA), holds 42.50K shares in Hansen Medical (Ticker: HNSN). Most recently, Christopher Lowe Bought ― shares of Vincerx Pharma Inc on Aug 26, 2022 for an estimated value of $49.20K.

Christopher Lowe's Trading History

VINC
Vincerx Pharma Inc
Aug 26, 2022DirectorInformative Buy49.20K$600.00
IRLA
IRulya Therapeutics
Mar 04, 2022Interim CEO, COO & CFOUninformative Buy―$10.55M
HNSN
Hansen Medical
May 20, 2014―Informative Buy28.80K$168.72K
ANTH
Anthera Pharmaceuticals
Mar 27, 2013CFO and Chief Business OfficerUninformative Buy――
RBSH
Rebus Holdings
―President and CEO, Director――

You May Also Like

Christopher Lowe insider profile FAQ

What is the percentage of profitable transactions made by Christopher Lowe?
The percentage of profitable transactions made by Christopher Lowe is 0%.
What is the average return per transaction made by Christopher Lowe?
The average return per transaction made by Christopher Lowe is -57.20%.
What stocks does Christopher Lowe hold?
Christopher Lowe holds: VINC, HNSN, RBSH, IRLA, ANTH stocks.
What was Christopher Lowe’s latest transaction?
Christopher Lowe’s latest transaction was an Informative Buy of $49.20K.
What was Christopher Lowe's most profitable transaction?
Christopher Lowe’s most profitable transaction was an Informative Buy of HNSN stock on May 20, 2014. The return on the trade was -25.10%.
What is Christopher Lowe's role in Vincerx Pharma Inc?
Christopher Lowe's role in Vincerx Pharma Inc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.